Tokyo Rosai Hospital
In research, Tokyo Rosai Hospital stands highest in Health Sciences (#15,908 of 20,462 worldwide) and Medicine (#17,213 of 17,978 worldwide), over all time.
- World rank, all time
- #36,090 of 42,892
- Rank in Japan
- #1,586 of 2,112
- Research works
- 337 ▼ 16% vs 2013–17
- Citations
- 2.5k 7.5 per fractional work
- Top-10% rate
- 3.1% record average 16.5%
- Open access
- 57% world 28%
What is Tokyo Rosai Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #15,908 of 20,462 | 2.0% | 261 | |
| MedicineField | #17,213 of 17,978 | 1.9% | 253 |
Each strip is that field’s whole ranked pool, with the notch where Tokyo Rosai Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Medicine 3.9×
- Immunology and Microbiology 3.1×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Health Professions 1.0×
- Neuroscience 0.7×
- Agricultural and Biological Sciences 0.4×
- Psychology 0.3×
- Engineering 0.2×
- Materials Science 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
Which keywords describe research at Tokyo Rosai Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Cardiovascular Disease, Prognostic Factors, Chemotherapy, Therapeutic Targets, Diagnosis, Surgical Management and Immunohistochemistry.
- Obesity
- Chromatin
- Treatment
- Clinical Practice Guidelines
- Stem Cells
- Gastric Cancer
- Breast Cancer
- Insulin Therapy
- Endoscopic Resection
- Surgery
- Adverse Drug Reactions
- Therapeutic Targets
- Metabolic Syndrome
- Management
- Prognostic Factors
- Cardiovascular Disease
- Epidemiology
- Diagnosis
- Chemotherapy
- Immunohistochemistry
- Surgical Management
- Molecular Profiling
- Diabetes
- Survival Analysis
- Glycemic Control
- Atherosclerosis
- Clinical Pharmacy
- Pharmaceutical Care
- Adjuvant Therapy
- Inflammation
- Cancer
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Epidemiology5▲ 3.4×23 topics
- Cardiovascular Disease2▲ 5.5×12 topics
- Diagnosis2▲ 5.5×9 topics
- Prognostic Factors2▲ 11×7 topics
- Chemotherapy2▲ 6.8×7 topics
- Management2▲ 5.8×8 topics
- Immunohistochemistry2▲ 58×3 topics
- Metabolic Syndrome2▲ 5.4×5 topics
- Surgical Management2▲ 10×6 topics
- Therapeutic Targets2▲ 29×3 topics
- Molecular Profiling2▲ 41×2 topics
- Adverse Drug Reactions1▲ 68×2 topics
- Diabetes1▲ 7.6×5 topics
- Surgery1▲ 11×6 topics
- Survival Analysis1▲ 14×3 topics
- Endoscopic Resection1▲ 36×2 topics
- Glycemic Control1▲ 22×3 topics
- Insulin Therapy1▲ 28×3 topics
- Atherosclerosis1▲ 12×5 topics
- Breast Cancer1▲ 14×3 topics
- Clinical Pharmacy1▲ 280×1 topic
- Gastric Cancer1▲ 27×3 topics
- Pharmaceutical Care1▲ 280×1 topic
- Stem Cells1▲ 13×4 topics
- Adjuvant Therapy1▲ 23×2 topics
- Clinical Practice Guidelines1▲ 5.4×3 topics
- Inflammation1▲ 1.46×10 topics
- Treatment1▲ 2.3×6 topics
- Cancer1▲ 2.0×6 topics
- Chromatin1▲ 57×2 topics
- Molecular Characterization1▲ 16×3 topics
- Obesity1▲ 3.6×4 topics
Which research topics does Tokyo Rosai Hospital publish most on?
By volume in 2022–2025: Pharmacy and Medical Practices, Gastric Cancer Management and Outcomes, Metastasis and carcinoma case studies and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacy and Medical Practices Pharmacology 1 works
- 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
- 3 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 1 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 5 Gastrointestinal Tumor Research and Treatment Gastroenterology 1 works
- 6 Chromosomal and Genetic Variations Plant Science 1 works
- 7 DNA Repair Mechanisms Molecular Biology 1 works
- 8 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 1 works
- 9 DNA and Nucleic Acid Chemistry Molecular Biology 1 works
- 10 Cancer Diagnosis and Treatment Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tokyo Rosai Hospital's research output changed?
Output in 2018–2022 was 16% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.